NAFLD - NON-ALCOHOLIC FATTY LIVER DISEASE
Clinical trials for NAFLD - NON-ALCOHOLIC FATTY LIVER DISEASE explained in plain language.
Never miss a new study
Get alerted when new NAFLD - NON-ALCOHOLIC FATTY LIVER DISEASE trials appear
Sign up with your email to follow new studies for NAFLD - NON-ALCOHOLIC FATTY LIVER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill aims to melt liver fat in 12 weeks
Disease control Recruiting nowThis study tests an experimental pill, HP515, in 80 adults with non-alcoholic fatty liver disease (NAFLD). The main goal is to see if it reduces liver fat over 12 weeks using MRI scans. Participants must have at least 10% liver fat and be aged 18-65. The trial also checks safety …
Matched conditions: NAFLD - NON-ALCOHOLIC FATTY LIVER DISEASE
Phase: PHASE2 • Sponsor: Hinova Pharmaceuticals Inc. • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New ultrasound test could replace painful liver biopsies for millions
Diagnosis Recruiting nowThis study is testing a new ultrasound method to measure fat in the liver without needles or expensive MRI scans. Researchers will compare the ultrasound results to MRI in 110 adults with or at risk for MASLD, a common liver condition linked to obesity and diabetes. If successful…
Matched conditions: NAFLD - NON-ALCOHOLIC FATTY LIVER DISEASE
Phase: NA • Sponsor: ContextVision AB • Aim: Diagnosis
Last updated May 22, 2026 14:01 UTC